TFFP News and Press, TFF Pharmaceuticals Inc - Ordinary Shares From 02/19/21

TFF Pharmaceuticals (TFFP) announces that the company obtained positive preclinical in vitro efficacy data regarding the thin film freezing ("TFF") formulated biodefense countermeasures.The studies were conducted in collaboration with the United States Army Medical Research Institut...

Company’s Thin Film Freezing maintained efficacy for two different biodefense countermeasures against Alphaviruses and Filoviruses TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative...

TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, will participate in the 2021 BIO CEO & Investor Digital Confere...

TFFP has in-licensed thin film freezing technology from UT Austin that lets it produce better formulations of existing drugs. The total addressable market runs into billions of dollars if the trials are successful. The company needs to protect its IP and get some funds. For ...

Corporate presentation available on demand beginning Monday, January 11, 2021 at 6:00 AM ET TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film...

TFF Pharmaceuticals ([[TFFP]] -1.0%) has dosed the first asthma subjects in its Phase 1b trial of voriconazole, direct to lung inhaled dry powder. This study in patients with asthma will assess the safety, pharmacokinetics, and induction of bronchospasm.The company is also adva...

Phase 1b Dosing of Voriconazole Inhalation Powder in asthma patients to evaluate safe dosing in patients with hyperreactive airways for direct-to-lung delivery of voriconazole for the treatment or prevention of Invasive Pulmonary Aspergillosis (IPA) Asthma patients with hyperr...

UK government scoops the US in authorizing the use of the Pfizer/BioNTech vaccine; roll out to commence next week. FDA and EU approval probably not far off. The Pfizer/BioNTech vaccine has first mover advantage. BioNTech stock could experience further gains at least in the short term....

Corporate presentation and live webcast scheduled for Thursday, November 19, 2020 at 2:55 PM ET TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin ...

TFF Pharmaceuticals, Inc. (TFFP) Q3 2020 Earnings Conference Call November 5, 2020 16:30 ET Company Participants Paul Sagan - Investor Relations Glenn Mattes - President and Chief Executive Officer Kirk Coleman - Chief Financial Officer Dale Christensen - Director, Clinical Development Chris ...